{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:18:57Z","timestamp":1780589937194,"version":"3.54.1"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,3,8]]},"DOI":"10.18632\/oncotarget.26754","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T14:21:31Z","timestamp":1552054891000},"page":"1957-1974","source":"Crossref","is-referenced-by-count":11,"title":["An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells"],"prefix":"10.18632","volume":"10","author":[{"given":"Haidong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Virology, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fang","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Virology, Ume\u00e5 University, Ume\u00e5, Sweden"},{"name":"Laboratory Medicine, Clinical Microbiology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.omto.2016.11.003","article-title":"Oncolytic group B adenovirus enadenotucirev mediates non-apoptotic cell death with membrane disruption and release of inflammatory mediators","volume":"4","author":"Hermiston","year":"2017","journal-title":"Mol Ther Oncolytics"},{"key":"2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Suzuki","year":"2016","journal-title":"Curr Opin Virol"},{"key":"3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-09-1960","article-title":"Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers","volume":"16","author":"Hallden","year":"2010","journal-title":"Clin Cancer Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/mt.2012.115","article-title":"Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer","volume":"20","author":"Hemminki","year":"2012","journal-title":"Mol Ther"},{"key":"5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Finberg","year":"1997","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"Philipson","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/JVI.77.2.1157-1162.2003","article-title":"There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses","volume":"77","author":"Wadell","year":"2003","journal-title":"J Virol"},{"key":"8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Drescher","year":"2011","journal-title":"Nat Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3892\/ijo.2012.1674","article-title":"A novel Ad5\/11 chimeric oncolytic adenovirus for improved glioma therapy","volume":"41","author":"Xia","year":"2012","journal-title":"Int J Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2004.07.018","article-title":"Human hematopoietic (CD34+) stem cells possess high-affinity receptors for adenovirus type 11p","volume":"328","author":"Wadell","year":"2004","journal-title":"Virology"},{"key":"11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2016.07.026","article-title":"Complete replication-competent adenovirus 11p vectors with E1 or E3 insertions show improved heat stability","volume":"497","author":"Silver","year":"2016","journal-title":"Virology"},{"key":"12","doi-asserted-by":"crossref","first-page":"e17532","DOI":"10.1371\/journal.pone.0017532","article-title":"Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells","volume":"6","author":"Mei","year":"2011","journal-title":"PLoS One"},{"key":"13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/hum.2007.124","article-title":"Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells","volume":"20","author":"Mei","year":"2009","journal-title":"Hum Gene Ther"},{"key":"14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/viro.1996.0295","article-title":"The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants","volume":"220","author":"Wold","year":"1996","journal-title":"Virology"},{"key":"15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2004.06.007","article-title":"Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms","volume":"326","author":"Ramachandra","year":"2004","journal-title":"Virology"},{"key":"16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/hum.2012.047","article-title":"Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy","volume":"23","author":"Morris","year":"2012","journal-title":"Hum Gene Ther"},{"key":"17","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1073\/pnas.84.23.8355","article-title":"A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters","volume":"84","author":"Green","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0092-8674(83)90215-5","article-title":"Activation of gene expression by adenovirus and herpesvirus regulatory genes acting in trans and by a cis-acting adenovirus enhancer element","volume":"35","author":"Nevins","year":"1983","journal-title":"Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/o88-068","article-title":"Transactivation by the adenovirus E1A gene","volume":"66","author":"Reichel","year":"1988","journal-title":"Biochem Cell Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1073\/pnas.88.20.9077","article-title":"Antioncogenic effect of adenovirus E1A in human tumor cells","volume":"88","author":"Frisch","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4899-5037-6_32","article-title":"Regulation of the metastatic phenotype by the E1A gene of adenovirus-2","volume":"233","author":"Khoury","year":"1988","journal-title":"Adv Exp Med Biol"},{"key":"22","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/MCB.8.7.2984","article-title":"The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells","volume":"8","author":"Khoury","year":"1988","journal-title":"Mol Cell Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/JVI.70.4.2296-2306.1996","article-title":"The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells","volume":"70","author":"Wold","year":"1996","journal-title":"J Virol"},{"key":"24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2013.05.003","article-title":"Enhanced growth of recombinant human adenovirus type 41 (HAdV-41) carrying ADP gene","volume":"176","author":"Estes","year":"2013","journal-title":"Virus Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(83)90011-9","article-title":"Cis-acting induction of adenovirus transcription","volume":"33","author":"Berk","year":"1983","journal-title":"Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0092-8674(90)90112-R","article-title":"Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation","volume":"62","author":"Nevins","year":"1990","journal-title":"Cell"},{"key":"27","first-page":"59","article-title":"Adenovirus E1A-dependent trans-activation of transcription","volume":"1","author":"Nevins","year":"1990","journal-title":"Semin Cancer Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/mt.2011.242","article-title":"Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11","volume":"20","author":"Wang","year":"2012","journal-title":"Mol Ther"},{"key":"29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2013.08.032","article-title":"Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapy","volume":"447","author":"Morrison","year":"2013","journal-title":"Virology"},{"key":"30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tranon.2017.07.002","article-title":"Immunohistochemical characterization and sensitivity to human adenovirus serotypes 3, 5, and 11p of new cell lines derived from human diffuse grade II to IV gliomas","volume":"10","author":"Jaaskelainen","year":"2017","journal-title":"Transl Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40425-017-0277-7","article-title":"Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection","volume":"5","author":"Calvo","year":"2017","journal-title":"J Immunother Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"e100665","DOI":"10.1371\/journal.pone.0100665","article-title":"In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14","volume":"9","author":"Qin","year":"2014","journal-title":"PLoS One"},{"key":"33","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/carcin\/18.6.1215","article-title":"Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18","volume":"18","author":"Rhim","year":"1997","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2016.04.029","article-title":"Replication-competent human adenovirus 11p vectors can propagate in Vero cells","volume":"495","author":"Mei","year":"2016","journal-title":"Virology"},{"key":"35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1099\/vir.0.19178-0","article-title":"Comparative analysis of the genome organization of human adenovirus 11, a member of the human adenovirus species B, and the commonly used human adenovirus 5 vector, a member of species C","volume":"84","author":"Wadell","year":"2003","journal-title":"J Gen Virol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T10:42:57Z","timestamp":1588848177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":35,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,3,8]]}},"alternative-id":["26754","30956777"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26754","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]}}}